These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24856595)

  • 1. Evaluation of an educational program on deciphering heterogeneity for medical coverage decisions.
    Warholak TL; Hilgaertner JW; Dean JL; Taylor AM; Hines LE; Hurwitz J; Brown M; Malone DC
    J Manag Care Spec Pharm; 2014 Jun; 20(6):566-73. PubMed ID: 24856595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Pharmacy and Therapeutic (P&T) Committee member knowledge, attitudes and ability regarding the use of comparative effectiveness research (CER) in health care decision-making.
    Tang DH; Warholak TL; Hines LE; Hurwitz J; Brown M; Taylor AM; Brixner D; Malone DC
    Res Social Adm Pharm; 2014; 10(5):768-80. PubMed ID: 24480384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection.
    J Manag Care Spec Pharm; 2020 Jan; 26(1):55-62. PubMed ID: 31880226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.
    Stebbins MR; Frear ME; Cutler TW; Lightwood JM; Fingado AR; Lai CJ; Lipton HL
    J Manag Care Pharm; 2013 Sep; 19(7):534-41. PubMed ID: 23964614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing heterogeneity in prescription drug coverage policies.
    Teagarden JR
    J Manag Care Spec Pharm; 2014 Jun; 20(6):564-5. PubMed ID: 24856594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
    Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
    J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
    Bowlus CL; Kenney JT; Rice G; Navarro R
    J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulary management in the Department of Defense.
    Trice S; Devine J; Mistry H; Moore E; Linton A
    J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for continuing pharmacy education.
    McConnell KJ; Newlon C; Dickerhofe J
    Am J Pharm Educ; 2009 Aug; 73(5):87. PubMed ID: 19777102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs.
    Yeung K; Suh K; Basu A; Garrison LP; Bansal A; Carlson JJ
    J Manag Care Spec Pharm; 2017 Oct; 23(10):1084-1090. PubMed ID: 28944726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy.
    2018-2019 Academy of Managed Care Pharmacy Professional Practice Committee
    J Manag Care Spec Pharm; 2019 Jun; 25(6):641-644. PubMed ID: 30977701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the AMCP Partnership Forum: NCPDP Electronic Prior Authorization Standards-Building a Managed Care Implementation Plan.
    AMCP Electronic Prior Authorization Work Group
    J Manag Care Spec Pharm; 2015 Jul; 21(7):545-50. PubMed ID: 26108378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving medical resident perceptions of health plan decision making.
    Mathis RS; Patric K; Tobey D; Martin S
    Am J Manag Care; 2005 Sep; 11(9):573-5. PubMed ID: 16159048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalfampridine prior authorization program: a cohort study.
    Gleason PP; Phillips J; Fenrick BA; Delgado-Riley A; Starner CI
    J Manag Care Pharm; 2013; 19(1):18-25. PubMed ID: 23383704
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.